Logo KMS TEAM
Precise execution

MC Services is...

Client News

 

 

… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.

 

read more

 

MC Services attends Bio€quity Europe

 

The MC Services Team is heading to Paris to attend the 18th Bio€quity Europe meeting. Organized by BioCentury and EBD Group, the collaborative gathering of corporate investment communities for the European life sciences will take place May 22-23 in Paris, France. Bio€quity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects. In its 18 year history, the event  has showcased more than 700 leading European companies to thousands of investment and pharma business development professionals.

 

Find out more

 

 

MC Services sponsors Best Technology Award at the 2017 European Mediscience Awards

 

MC Services is proud to contribute to this year’s European Mediscience Awards as a sponsor of the Best Technology Award, for innovative technology that is well funded and capable of significant commercial success.

 

Mediscience Awards 2017 shortlist announced


It is done: after much anticipation, the voting has taken place and the shortlist for the 2017 Mediscience Awards has been announced! A huge congratulation to all the shortlisted companies!


The winners will be crowned on Thursday June 15th at European Mediscience Awards prestigious dinner which is being held at The Brewery, London, EC1. Don’t miss out on Europe’s largest annual awards gathering of private and publicly quoted mediscience companies and their advisors, an absolute must-attend networking event for anybody working in this field.

 

See here for the full shortlist.

Publication of UK Annual Report and Accounts & Notice of AGM

www.motifbio.com

VAXIMM Announces Data from Phase I Trial in Glioblastoma with Oral T-cell Immunotherapy VXM01 to be Presented at ASCO 2017 Annual Meeting

www.vaximm.com

Cinfa Biotech announces positive top-line data from second clinical study with pegfilgrastim biosimilar candidate B12019

www.cinfabiotech.com

Newron Pharmaceuticals Announces Expansion of STARS Study to Include Patients Under 13 Years of Age

www.newron.com

Ms. Lauren P. Silvernail appointed to Nicox Board of Directors

www.nicox.com

NOXXON PHARMA announces collaboration with National Center for Tumor Diseases in Heidelberg for NOX-A12/KEYTRUDA® Phase 1/2 Combination Trial

www.noxxon.com

Probiodrug AG Announces Acceptance of PQ912 Pharmacology Paper by Peer Reviewed Journal

www.probiodrug.de

SYGNIS AG resolves share price of EUR 1.38 for announced capital increase of up to ten percent of share capital

www.sygnis.com

Newron Receives EUR11.3m Milestone Payments for US Approval of Xadago® (safinamide)

www.newron.com

Probiodrug AG reports First Quarter 2017 Business Update

www.probiodrug.de